Tuesday 13 August 2019

Kidney Dialysis Equipment Market to Witness Huge Growth by 2023 Says MRFR

Market Analysis
The global kidney dialysis equipment market is touted to accumulate USD 16.5 billion at a stupendous 5.7% CAGR during the assessment period (2018-2023). CKD or chronic kidney disease is a chronic condition which seriously impacts a patient’s quality of life. Kidney dialysis is the most preferred treatment for severe conditions where both the kidneys of a person is damaged but this treatment is also occasionally used for treating patients with a single damaged kidney. Every day, the kidney of a healthy person filters about 150 quarts of blood. Should an individual’s kidney fail to function efficiently automatically the waste will get collected in the blood resulting in coma and even death. Here dialysis will act as the savior. It will stop the toxin and waste products formation in the blood. It is an artificial kidney that is used for filtering the blood of the patient during kidney failure, kidney dysfunction and kidney damage and for removing surplus impurities from kidneys.


There are many factors that is driving the growth of the kidney dialysis equipment market. Some of these factors as per the Market Research Future (MRFR) report include new funding channels in the healthcare sector, increase in the prevalence of dialysis patients, better healthcare infrastructure, adoption of latest technologies in dialysis, loss of appetite causing weight loss, change in sedentary lifestyle, heart failure, growing acidosis, growing number of ESRD (End Stage Renal Disease Patients), increase in accurate and cost-effective portable dialysis apparatus, fast growth in geriatric population, growing frequencies of hypertension and diabetes problems and preference for dialysis over kidney transplantation. On the contrary, factors such as difficulties and risks involved, time consumption, regulations and rules associated with dialysis, expensive treatments and soaring cost of dialysis procedures may take a toll on the growth of the kidney dialysis equipment market over the assessment period.

Key Players
Leading players profiled in the kidney dialysis equipment market include Hemoclean CO., LTD, Teleflex Incorporated, Rockwell Medical, Terumo Corporation, Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation), Mar Cor Purification, Inc. (A Cantel Medical Company), Nikkiso Co., Ltd., Nxstage Medical, Inc., Nipro Corporation, Diaverum Deutschland GmbH, B. Braun Melsungen AG, Baxter International Inc., Davita Healthcare Partners Inc and Fresenius Medical Care AG & Co. Ka.

Market Segmentation
Market Research Future report offers an all-inclusive segmental analysis of the kidney dialysis equipment market on the basis of type, apparatus type and end-user.
Based on type, it is segmented into Continuous Renal Replacement Therapy (CRRT), peritoneal dialysis and hemodialysis. Hemodialysis is further segmented into nocturnal hemodialysis, short daily hemodialysis and conventional hemodialysis. The Peritoneal dialysis is further segmented into Tidal Peritoneal Dialysis, Intermittent Peritoneal Dialysis (IPD), Continuous Cycling Peritoneal Dialysis (CCPD) and Continuous Ambulatory Peritoneal Dialysis (CAPD).

Based on apparatus type, the kidney dialysis equipment market is segmented into consumables and continuous renal replacement therapy systems, peritoneal dialysis equipment and hemodialysis equipment. The hemodialysis equipment us further segmented into vascular access devices, tunneled hemodialysis catheters, concentrates and solutions, bloodline system, dialyzers and filters and hemodialysis machine. The peritoneal dialysis equipment is segmented into filters, dialyzers, automated peritoneal dialysis machines and concentrates and solutions. Of these, the hemodialysis equipment will grab the maximum market share.
Based on end-user, the kidney dialysis equipment market is segmented into ambulatory services, home care, in-center dialysis settings and hospitals.

Regional Analysis
Based on region, the kidney dialysis equipment market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America is likely to command the market owing to the rising incidence of kidney failure, rising cases of diabetes and hypertension and higher reusable income amid people. Europe will have the second biggest share due to advanced medical compensation and progressive organizations. The kidney dialysis equipment market in APAC possess an unprecedented market potential owing to increasing incidences of kidney failure, increase in disposable income, presence of large geriatric population and low rates of organ transplantation. The kidney dialysis equipment market in the Middle East and Africa will have minimal share owing to low per capita income and stringent government policies.

Feb 2019- Leading dialysis service provider, US Renal Care, Inc will be acquired by Investor Group with an aim to improve the quality of life for those having chronic renal disease.

April 2018- MRCS (Malaysian Red Crescent Society) and KDC (Kidney Dialysis Centre) off late has received accolades for their success to help countless patients in the last 22 years.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Kidney Dialysis Equipment Market, By Type
6.1 Introduction
6.2 Hemodialysis
6.2.1 Conventional Hemodialysis

Latest Trending Reports




About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Monday 12 August 2019

Urology Devices Market Growing Strong With Top Key Players- Urology Devices Market Growing Strong

Market Synopsis:Market Research Future (MRFR)’s latest report reveals that the global urology devices market is poised to thrive at 7.1% CAGR during the forecast period 2017 to 2023. Urology devices are effective in the treatment of ailments related to organs such as adrenal glands, urinary bladder, ureters, urethra, etc. In addition, the rising prevalence of diseases associated with male reproductive organs and female urinary tract system is likely to expedite the growth of the urology devices market in the upcoming years.
Urology device finds application in the treatment of diseases such as prostate cancer, traumatic injury, kidney stones, and congenital abnormalities among others. The increasing patient pool of these diseases is projected to catapult the urology devices market on the trajectory of growth during the projection period.
Investments are prognosticated to flow towards research & development of these devices. This, in turn, is anticipated to augment the urology devices market in the forthcoming years. The market is forecasted to remain highly lucrative over 2023. Furthermore, an expansion of market presence for these devices is foreseen, which is predicted to catalyze the proliferation of the global urology devices market. Nevertheless, expensiveness of urology devices remains impediments to market growth.
Market Segmentation:On the basis of type, the global Urology Devices Market has been segmented into dialysis equipment, urinary stone treatment devices, dialysis equipment, endoscopy devices, urinary incontinence & pelvic organ prolapsed devices, benign prostatic hyperplasia treatment devices, and others.
The dialysis equipment segment is further sub-segmented into hemodialysis, peritoneal dialysis, and others.
The urinary stone treatment devices segment has been sub-segmented into lithotripsy, ureteral stents, and others.
The urinary incontinence & pelvic organ prolapsed devices segment are sub-segmented into urethral inserts & pessaries, sacral neuromodulator, vaginal meshes & slings, and others.
The benign prostatic hyperplasia treatment devices segment has been further sub-segmented into catheter ablation, prostatic stents, and others.
On the basis of technology, the urology devices market has been segmented into robotic surgery, minimally invasive surgery, and others.
On the basis of application, the global urology devices market has been segmented into prostate cancer, urinary stones, benign prostatic hyperplasia, urinary incontinence, and others.
On the basis of end-users, the urology devices market is segmented into ambulatory services, hospitals, and others.

Regional Insights:The Global Urology Devices Market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas presently account for the largest share of the global market. It is expected to exhibit significant growth over the assessment period owing to technological developments, increasing healthcare expenditure and rising prevalence of diseases such as kidney stones, traumatic injury, etc.
Europe has the second largest share of the global urology devices market and is expected to retain its market share towards the end of the forecast period. The growth can be ascribed to the rising geriatric population and accelerated investments in research & development.
Asia Pacific is an extremely lucrative market and has been prognosticated to strike the highest CAGR over the projection period. The strong economic growth of the region coupled with developments in the healthcare sector is projected to drive the growth of the regional market. Meanwhile, the Middle East & Africa is poised to witness limited growth due to limited availability of standard healthcare facilities in certain regions.

Competitive Landscape:Some of the key players profiled in the report are Medtronic (US), Boston Scientific Corporation (US), Karl Storz GmbH & Co. KG (Germany), Olympus Corporation (Japan), C. R. Bard, Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), Cook (US), Dornier MedTech (Germany), Nikkiso Co. Ltd (Japan), Stryker (US), and HealthTronics, Inc (US).

Industry News:In April 2018, Dornier MedTech, a medical device company, has started direct sales in the U.S. for its Surgical Holmium Lasers and Fibers.
In November 2018, NeoTract, a manufacturer of devices in the field of urology, has received Shonin approval for UroLift® System which is useful in the treatment of benign prostatic hyperplasia (BPH).
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Table Of Contents
1 Introduction
1.1 Definition
1.2 Scope Of The Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model

Health Care Industry Reports



 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Sunday 11 August 2019

Superdisintegrants Market Size, Share, Trend Growth | Industry Analysis Report 2018-2023

Market Insights
Oral administration of medical drugs in the form of tablets and capsules is one of the most commonly prescribed methods for drug delivery due to several key factors ranging from being easy to swallow to better chemical stability in this form. Superdisintegrants have become a vital addition to tablets and capsules as they facilitate rapid disintegration of smaller doses than conventional disintegrants making them ideal for various medical applications in the pharmaceutical sector. Market Research Future's new publication on the global superdisintegrants market has observed the growth of the market at a healthy CAGR of 7.9% during the forecast period from 2018 to 2023. At the beginning of the forecast period in 2017, the market generated a revenue of USD 371.3 Mn. The projected rate of growth is anticipated to establish the market at a value of USD 576.2 Mn by the end of the review period in 2023
The global pharmaceutical industry has witnessed a significant spike in its growth over the past few years, and this growth is expected to continue in the coming years. Many patents on popular drugs have expired or are likely to expire soon, which has prompted the entry of new competitors and the production of generic drugs. Increasing production of generic drugs is expected to cause a rise in demand for superdisintegrants. Moreover, superdisintegrants are used highly in the production of drugs which are aimed at geriatric and pediatric patients as they offer good disintegration and efficacy at low dosages. The ever-expanding aged and infant population is likely to impact the global superdisintegrants market in a positive manner.
Emerging economies offer the global superdisintegrants market with considerable opportunities for growth over the forecast period. The prevalence of several chronic diseases combined with the rapidly expanding healthcare sector in the region will contribute to future growth of the market. 
Market Segmentation
MRFR's analysis of the various segments in the market has been performed on the basis of type, formulation, therapeutic area, and region. Types of superdisintegrants have been segmented into synthetic superdisintegrants, natural disintegrants, and others. Among these, the synthetic superdisintegrants segment has been widely used, making it the most significant market segment. However, the natural superdisintegrants segment is growing at a truly rapid pace due to the growing demand for natural ingredients.
Formulations which include superdisintegrants have been segmented into tablets and capsules. Tablets govern a majority share of the total market, while the capsules segment is expected to grow at the highest CAGR during the review period.
Therapeutic areas where superdisintegrants are used have been segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, inflammatory diseases, hematological diseases, and cardiovascular diseases. Among these segments, the gastrointestinal diseases segment is at the forefront of market growth due to the demand for fast acting medicine for these types of diseases. Meanwhile, the oncology segment is growing rapidly and is expected to display the highest CAGR over the forecast period.
 Regional Analysis
Led by the U.S, the Americas have captured the largest share of the global Superdisintegrants Market. The presence of a developed healthcare sector as well as several important market players that have and continue to influence growth and contribute to the sizeable share that this regional market possesses. The region also has a high demand for drugs for many chronic diseases where superdisintegrants are required due to the prevalence of such diseases.
The Asia Pacific superdisintegrants market is likely to grow at the highest pace due to the concentration of rapidly emerging markets in the region. China, Japan, India, and several other country-level markets have a high demand for drugs for chronic diseases. The APAC regional market has several avenues for growth that are expected to open up in the coming years. The regions rapidly growing healthcare sector and the presence of a number of contract manufacturing organizations for pharmaceuticals is likely to have a positive impact on the market.
Key Players
Analysis of the competitive landscape of the global superdisintegrants market includes several important market players such as DFE Pharma, Roquette Freres, BASF SE, Ashland Global Holdings Inc., JRS Pharma, Merck KGaA, DowDuPont Inc., Avantor Performance Materials, LLC, Corel Pharma Chem, and Asahi Kasei Corporation.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction 
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Superdisintegrants Market, By Type
...
Access Report Details @ https://www.marketresearchfuture.com/reports/superdisintegrants-market-6663
Related Reports
Cancer Registry Software Market Research Report - Global Forecast till 2024
Artificial Neural Network Market Research Report – Forecast to 2023
Global Cancer Biological Therapy Market Research Report- Forecast to 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , ,

Thursday 8 August 2019

Latest Qualitative Report on Porcine Vaccines Market to Witness a Robust Growth in CAGR by 2023 | Top Key Players: Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale

Market Highlights
The global porcine vaccines market held a market value of USD 1910.7 million in 2017 and is projected to grow at a CAGR of 7.1% over the forecast period. Porcine vaccines aid the swine or hogs suffering from epidemic swine diseases. It also helps in improving overall efficiency in protecting swine from deadly viruses, bacteria and increases the production level of high-quality meat and gelatine. The increasing prevalence of swine diseases such as PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), swine influenza etc. are anticipated to drive the market growth during the forecast period.  Additionally, rising number of biotechnology companies, research institutions engaged in research and development of porcine vaccines, and government initiatives for funding agriculture and animal husbandry sector and increasing demand for porcine meat and gelatine are likely to contribute to the market growth. For instance, by the world by per-capita pig meat consumption, US has an average of 64.4 kilos of meat consumed in 2017. According to National Pork Producers Council the pork production has an estimated USD 23.4 billion of gross output nationwide. However, high cost of maintaining vaccines may hamper the market growth during the assessment period.

Market Segmentation
The global porcine vaccines market segmentation is divided on the basis of disease indication, type, region, and end-user.
By type, the market includes Conjugate vaccines, live attenuated vaccines, inactivated vaccines, Toxoid vaccines, DNA vaccines, and Recombinant vaccines.
By disease indication, the market segments into Swine influenza, PED (Porcine Epidemic Diarrhea), Porcine Circovirus Associated Disease (PCVAD), PRRS (Porcine Reproductive & Respiratory Syndrome), Aujeszky's disease (AD), and others.
By end-user, the market divides into Hog Production Farm and Veterinary Hospitals.
By region, the porcine vaccines market covers Americas, Asia Pacific, Europe, and the Middle East and Africa. Furthermore, North America breaks into the US and Canada; Asia Pacific divides into India, China, Japan, South Korea, Australia, and Rest of Asia Pacific; Europe divides into Western and Eastern Europe.
Key Players
Some of the prominent players in the global porcine vaccines market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck & Co., Inc., Sanofi S.A., Vetoquinol S.A., Zoetis, Inc., PBS Animal Health, Aptimmune. 
Regional Analysis
Among the mentioned regions covered by the porcine vaccines market, the Americas hold the dominant share and stand tall with the leading position. The growth and positioning of the region can be owed to the rising number of pig farms and rising swine-based diseases like swine influenza, PED (Porcine Epidemic Diarrhea), PRRS (Porcine Reproductive & Respiratory Syndrome), etc. Add to this, the fast-paced increase in contract farming as well as independent farming for the cultivation of pig is also identified as a major driver of the regional market.
Europe holds the second largest position in the global porcine vaccination market and is expected to retain its positioning in the forthcoming years of the forecast period. The growth of the market is attributed to the expanding number of production units for swine and a high consumption rate of pork meat.
The Asia Pacific region is expected to hold the potential to be the fastest growing region in the porcine vaccines market. The factors contributing to the growth of the market are animal associations, initiatives undertaken by various government agencies, and high opportunities of growth for major players in the market in regard to setting up their manufacturing plants in the region.
The Middle East & Africa region boasts the least share in the global porcine vaccines market. The region is anticipated to be majorly spearheaded by the Middle East due to the increasing government initiatives for the animal care industry.
April 12th, 2019, MSD Animal Health made an announced concerning the launch of its new and innovative triple action sowcare vaccine to fight against lep-tospirosis, porcine parvovirosis, and erysipelas. This one of a kind immunity vaccine against three dangerous diseases is a huge development in the industry.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Wednesday 7 August 2019

Know more about Anticholinergic Drugs Market 2019| Pfizer, Allergan Plc, Astellas Pharma, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd, Sanofi

Anticholinergic Drugs Market Highlights
The Global Anticholinergic Drugs Market is projected to reach USD 7,149.90 Million by 2024 at a CAGR of 4.50% during the review period from 2019 to 2024.
. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.
The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.
Anticholinergic Drugs Market- Segment Analysis
The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, semi-synthetic compounds. The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, muscle spasms, irritable bowel syndrome. On the basis of route of administration, the market is segmented into oral, parenteral, topical. On the basis of end user, the market is segmented into hospitals and pharmacies.
 Regional Analysis
The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.
Key Findings of the Study
  • The Global Anticholinergic Drugs Market is projected to reach USD 7,149.90 Million by 2024 at a CAGR of 4.50% during the review period from 2019 to 2024.
  • Americas accounted for the largest share of the global market due to the high prevalence of CNS diseases and demand for effective therapies.
  • The overactive bladder application segment accounted for the largest market share of 4% in 2018.
Intended Audience
  • Pharmaceutical Companies
  • Research and Development Organizations
  • Academic Institutes
Anticholinergic Drugs Market Studied By Top Players
Market Research Future (MRFR) recognizes following companies as key players in the global anticholinergic drugs market that include Pfizer Inc. (US), Allergan Plc (US), Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Sanofi (France), GlaxoSmithKline Plc (UK), Boehringer Ingelheim International GmbH (Germany) and others.
 List Of Table
Table 1 List Of Assumptions 15 
Table 2 Global Anticholinergic Drugs Market, By Type 2016-2024 (Usd Million) 32 
Table 3 Global Anticholinergic Drugs Market For Synthetic Compounds, By Region, 2016–2024 (Usd Million) 32 
Table 4 Global Anticholinergic Drugs Market For Natural, By Region, 2016–2024 (Usd Million) 33 
Table 5 Global Anticholinergic Drugs Market For Semi-Synthetic Compounds, By Region, 2016–2024 (Usd Million) 33
Table 6 Global Anticholinergic Drugs Market, By Application 2016-2024 (Usd Million) 36 
Table 7 Global Anticholinergic Drugs Market For Overactive Bladder, By Region, 2016–2024 (Usd Million) 36 
Table 8 Global Anticholinergic Drugs Market For Parkinson’s Disease, By Region, 2016–2024 (Usd Million) 37 
Table 9 Global Anticholinergic Drugs Market For Chronic Obstructive Pulmonary Disease (Copd), By Region, 
2016–2024 (Usd Million) 37 
Table 10 Global Anticholinergic Drugs Market For Muscle Spasms, By Region, 2016–2024 (Usd Million) 38 

Hottest Trending Reports




 About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,

Healthcare Consulting Services Market to Register a Steady Expansion at CAGR 10.4% by 2024

Market Insight
The healthcare consulting services market is getting positive vibes across the globe due to its smooth functioning of diverse activities in less amount of time. Market Research Future has published a report on global healthcare consulting services market, which states that the market is anticipated to grow positively at a CAGR of 10.4% during the forecast period of 2019 to 2024.

Healthcare consultant or healthcare consulting services is considered to be a business that is associated with providing services that are used by healthcare companies, hospitals, clinics, to instrument a new strategy for proper management of activities such as accounting, marketing, finance, insurance in the healthcare industry. These are essential factors that are contributing to the growth of the market significantly.

Key players for Global Healthcare Consulting Services Market

  • Accenture Consulting (US)
  • McKinsey and Company (US)
  • Cognizant (US)
  •  Deloitte Consulting (US)
  •  Ernst and Young (UK)
  •  Bain and Company (US)
  •  Deloitte Touche Tohmatsu Limited (US)
  •  Huron Consulting (US)
  •  KPMG (Switzerland)
  •  PWC (UK)
  •  The Boston Consulting Group (US)

Market Drivers & Trends
The global healthcare consulting services market is on the verge of growing due to an increase in the demand for healthcare consulting services across the globe. The surge in demand is causing for increasing globalization, rising demand for healthcare products, and the addition of a new few features in the healthcare industry.
Apart from this, the growing competition in the healthcare sector has also fortified significant companies to focus on the development of their business strategies. The development of the product, it's manufacturing, designing, and marketing also depends on the growth of the market. Therefore, these factors are claiming to be advantageous for the global healthcare consulting services market for tremendous growth over the assessment period.
Other prominent factors such as growth in the global aging population, the rising worth of valuable care as well as technical developments in the healthcare industry are driving the growth of the market exponentially.
However, on the flip side, the factors such as the availability of similar technology and low product differentiation may pose as a hamper to the global healthcare consulting services market growth. Besides, the problem of data confidentiality is also expected to be a hamper to the growth of the market to an extent during the forecast period.
Intended Audience
  • Biotechnological Institutes Hospitals and Clinics
  • Ambulatory Care Centers & Home Care Settings
  • Pharmaceutical & Biotech Companies
  • Government Healthcare Institutes
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers

Market Segmentation
The segmentation of the global healthcare consulting services market has been done based on the type of services, component, application, and end-user.
By type of services: IT consulting, digital consulting, financial consulting, operations consulting, and strategy consulting is the segments.
By component: Services, software, and hardware are the segments.
By application: operations management, financial, population health, and clinical are the segments. Operations management is further sub-segmented into demand forecasting, workforce planning and scheduling, inpatient scheduling, and outpatient scheduling. Then based on population health, the segments under it are population risk management, patient engagement, population therapy management, and others.
While by finance, the market is sub-segmented into revenue cycle management, fraud detection, an based on clinical the market is sub-segmented into quality benchmarking, patient care enhancement, and clinical outcome analysis and management.
By the end-user, hospitals and clinics, life science companies, and government bodies are the segments.

Regional Outlook
The Americas dominate the global healthcare consulting services market owing to the increase in healthcare infrastructure, growing awareness about the patient safety methods and increasing competition in healthcare companies opts for healthcare consultants for various solution and strategies which increases the demand for healthcare consulting services within the region.
Europe is second in the global healthcare consulting services market owing to increasing adaption of IT services in healthcare and increasing awareness about the healthcare consulting services is promoting the market across the globe.
The Asia-Pacific region is the fastest growing market owing to the increasing patient population, rising demand for various healthcare facilities for better treatment and increasing healthcare expenditure drives the market with the region. The Middle East & Africa has the least share in the global healthcare consulting services market owing to the presence of poor economies and low per capita income, especially in the African region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Monday 5 August 2019

Substance Abuse Treatment Market Will Reflect Significant Growth Prospects of 11.6% CAGR during 2017-2023

Market Highlights
Global substance abuse treatment market is projected to witness a strong growth over the next several years. As per the latest report published by Market Research Future (MRFR), the global substance abuse treatment market will surge at 11.6% CAGR during the forecast period (2018-2023). Today, substance abuse is endemic all around the wold with teenagers being the main victims.
Demand for substance abuse treatment is fuelled by rising number drug addiction cases, improvement in overall treatment approach, rising patient awareness regarding the benefits of substance abuse treatment and growing government support. Nonetheless, treatment compliance remains poor developing countries. In addition, reluctance or negligence among individuals is viewed as major challenge. 
Key Players
Some of the key players in the global substance abuse treatment market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., Purdue Pharma LP, Allergan, Mylan Laboratories, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceuticals, Forest Laboratories, Inc., Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharmaceuticals, and others.
Substance Abuse Treatment Market Regional Insight
The primary markets for substance abuse treatment are Europe, the Americas, Middle East & African and Asia Pacific.
In 2017, the Americas was identified as the leading substance abuse treatment market. The market’s prominence is the result of the presence of esteemed players, coupled with the mounting awareness about substance abuse treatment. In the past few years, several private, as well as government organizations, have been launching campaigns and seminars with the aim of spreading awareness about substance abuse. This works wonders for the regional market. Citing a reference, in February 2017, the Ad Council, along with Viacom, launched the LISTEN campaign which spoke about America’s substance abuse crisis.
In 2017, it was estimated that Europe stood second in the global substance abuse treatment market. The regional market benefits from the rise in research and development investments as well as increasing number of initiatives by the government to treat substance abuse patients.
With the fastest growth rate in the market in 2017, Asia Pacific is soaring high on the back of growing incidences of tobacco addiction coupled with the surge in technological advancements. The Frontiers in Psychiatry journal reveals that China faces massive public health challenge due to progressing tobacco smoking. It is reported that the number of deaths by cigarette smoking could reach the valuation of 2 million by 2030 and finally reach 3 million by 2050.
Lastly, Middle East and Africa accounted for the smallest share in the global substance abuse treatment market. The low per capita income, particularly in Africa, could be the main reason for the lackluster market performance.
Segmentation
The Global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.
Global Substance Abuse Treatment Market, by Abuse Type
  • Alcohol Dependence
  • Tobacco/Nicotine Addiction
  • Drug Abuse
  • Others
Global Substance Abuse Treatment Market, by Treatment Type
  • Alcohol Addiction Treatment
    • Disulfiram
    • Acamprosate
    • Naltrexone
  • Tobacco/Nicotine Addiction Treatment
    • Nicotine Replacement Treatment
      • Nicotine Patch
      • Nicotine Gum
      • Nicotine Lozenge
      • Nicotine Spray
      • Nicotine Inhaler
    • Non-Nicotine Medication
      • Bupropion
      • Varenicline
  • Drug Abuse Treatment
    • Methadone
    • Buprenorphine
    • Naltrexone
Global Substance Abuse Treatment Market, by End User
  • Outpatient Treatment Centers
  • Residential Treatment Centers
  • Inpatient Treatment Centers
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , , ,
Subscribe to: Posts (Atom)